The pharmaceuticals company Glenmark Pharma Ltd introduce medicine for the time with the combination of Teneligliptin (20mg) and Dapagliflozin (5mg/10mg) for the treatment of adult patients with type two diabetes, especially the ones with comorbidities.
- Vedanta Outlook for the Week (May 20, 2024 – May 24, 2024)
- Tata Steel Outlook for the Week (May 20, 2024 – May 24, 2024)
- PFC Outlook for the Week (May 20, 2024 – May 24, 2024)
- Piramal Enterprises Outlook for the Week (May 20, 2024 – May 24, 2024)
- MANAPPURAM Outlook for the Week (May 20, 2024 – May 24, 2024)
‘Zita D’ which contains Teneligliptin (20mg) andDapagliflozin (5 mg/10 mg). This medicine can be consumed by the patient once a day daily as per prescription, which helps to improve glycemic control and prevent complications in adult patients with type two diabetes, especially the ones with comorbidities, as per the statement said.